RAYMOND C. STEVENS, PHD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DANAHER CORP /DE/

Filing Date Source Excerpt
2020-03-25 Professor Stevens has served as Provost Professor of Biological Sciences and Chemistry ... Raymond C. Stevens, Ph.D. (3) 0 $209,120 $89,958 $299,078
2021-03-25 Professor Stevens has served as Provost Professor at USC. Committees: Science & Technology. Compensation: $302,582.
2022-03-30 Professor Stevens is CEO of ShouTi. Committees: Science & Technology. Compensation: $309,048.
2023-03-29 Professor Stevens has served as Chief Executive Officer of Structure Therapeutics (formerly known as ShouTi), a biotechnology company, since May 2019. He also served as Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the University of Southern California, a private research university, from July 2014 to August 2021. From 1999 until July 2014, he served as Professor of Molecular Biology and Chemistry with The Scripps Research Institute, a non-profit research organization. Professor Stevens has also launched multiple biotechnology companies focused on drug discovery.
2024-03-27 Professor Stevens has served as Chief Executive Officer of Structure Therapeutics (formerly known as ShouTi), a biotechnology company, since May 2019. He also served as Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the University of Southern California, a private research university, from July 2014 to August 2021.
2025-03-26 Professor Stevens is considered among the world’s most influential biomedical scientists in molecular research.

Data sourced from SEC filings. Last updated: 2025-08-30